Skip to main content

DELAFIELD, Wis. (Stockpickr) -- As part of a daily routine as an active trader or investor, one should always be tracking the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Genocea Biosciences

Genocea Biosciences (GNCA) - Get Genocea Biosciences, Inc. Report, a clinical stage biotechnology company, discovers and develops novel vaccines to treat infectious diseases. This stock is trading up 4.9% to $8.90 in Thursday's trading session.

Thursday's Range: $8.60-$8.95
52-Week Range: $6.15-$23.99
Thursday's Volume: 259,000
Three-Month Average Volume: 33,812

From a technical perspective, GNCA is ripping higher here right off some near-term support at $8.50 and right above its 50-day moving average of $8.21 with above-average volume. This spike to the upside on Thursday is now quickly pushing shares of GNCA within range of triggering a big breakout trade above some key near-term overhead resistance levels. That trade will trigger if GNCA manages to take out some near-term overhead resistance levels at $9 to $9.25 with high volume.

Traders should now look for long-biased trades in GNCA as long as it's trending above its 50-day moving average of $8.21 or above more near-term support at $8.18 and then once it sustains a move or close above those breakout levels with volume that hits near or above 33,812 shares. If that breakout hits soon, then GNCA will set up to re-test or possibly take out its next major overhead resistance levels at $9.75 to $10.50, or even its 200-day moving average of $11.42.

TheStreet Recommends

Aoxing Pharmaceutical

Aoxing Pharmaceutical (AXN) , a specialty pharmaceutical company, researches, develops, manufactures and distributes various narcotic, pain-management and addiction treatment pharmaceutical products primarily in the People's Republic of China. This stock is trading up 8.4% to $1.54 in Thursday's trading session.

Thursday's Range: $1.38-$1.59
52-Week Range: $0.18-$2.58
Thursday's Volume: 568,000
Three-Month Average Volume: 455,610

From a technical perspective, AXN is ripping higher here with above-average volume. This stock has been uptrending over the last few weeks, with shares moving higher from its low of 76 cents per share to its recent high of $1.63. During that uptrend, shares of AXN have been making mostly higher lows and higher highs, which is bullish technical price action. This spike to the upside on Thursday is now quickly pushing shares of AXN within range of triggering a big breakout trade. That trade will hit if AXN manages to take out some key near-term overhead resistance at $1.63 with high volume.

Traders should now look for long-biased trades in AXN as long as it's trending above some near-term support just below $1.40 or around $1.20 and then once it sustains a move or close above $1.63 with volume that hits near or above 455,610 shares. If that breakout kicks off soon, then AXN will set up to re-test or possibly take out its next major overhead resistance levels at $2 to its 52-week high of $2.58.



NephroGenex

NephroGenex (NRX) , a pharmaceutical company, focuses on developing therapeutics to treat kidney disease. This stock is trading up 2.2% to $8.22 in Thursday's trading session.

Thursday's Range: $8.00-$8.44
52-Week Range: $3.96-$17.98
Thursday's Volume: 54,000
Three-Month Average Volume: 555,953

From a technical perspective, NRX is spiking modestly higher here right off its 50-day moving average of $7.93 with lighter-than-average volume. This stock has been uptrending over the last few weeks, with shares moving higher from its low of $6.01 to its recent high of $8.69. During that uptrend, shares of NRX have been making mostly higher lows and higher highs, which is bullish technical price action. This trend to the upside on Thursday is now starting to push shares of NRX within range of triggering a major breakout trade above some key near-term overhead resistance levels. That trade will hit if NRX manages to take out some near-term overhead resistance levels at $8.45 to $8.69 with high volume.

Traders should now look for long-biased trades in NRX as long as it's trending above its 50-day moving average of $7.93 or above some more key near-term support at $7.80 and then once it sustains a move or close above those breakout levels with volume that registers near or above 555,953 shares. If that breakout develops soon, then NRX will set up to re-test or possibly take out its next major overhead resistance levels at $9.20 to $9.50, or even $11.

This article is commentary by an independent contributor. At the time of publication, the author held TK positions in the stocks mentioned.